From: Long term trends of breast cancer incidence according to proliferation status
Molecular subtype | Molecular marker |
---|---|
Luminal A | ER+ and/or PR+, HER2−, Ki-67 < 15% |
Luminal B (HER2−) | ER+ and/or PR+, HER2−, Ki-67 ≥ 15% |
Luminal B (HER2+) | ER+ and/or PR+, HER2+ |
HER2 type | ER−, PR−, HER2+ |
Basal phenotype | ER−, PR−, HER2−, CK5+ and/or EGFR+ |
5 negative phenotype | ER−, PR−, HER2−, CK5−, EGFR− |